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pt received January 24, 20his study sought to compare long-term survival after off- and on-pump coronary artery bypass grafting (CABG).Background Although several large-scale clinical trials have compared the surgical outcomes between off- and on-pump CABG,
the long-term survival has not been compared between the 2 surgical strategies in a reasonably sized cohort.Methods We evaluated long-term survival data in 5,203 patients (age 62.9  9.1 years, 1,340 females) who underwent
elective isolated CABG (off-pump: n ¼ 2,333; on-pump: n ¼ 2,870) from 1989 through 2012. Vital statuses were
validated using the Korean National Registry of Vital Statistics. Long-term survival was compared with the use of
propensity scores and inverse probability weighting to adjust selection bias.Results Patients undergoing on-pump CABG had a higher number of distal anastomoses than those undergoing off-pump
CABG (3.7  1.2 vs. 3.0  1.1; p < 0.001). Survival data were complete in 5,167 patients (99.3%), with a median
follow-up duration of 6.4 years (interquartile range: 3.7 to 10.5 years; maximum 23.1 years). During follow-up,
1,181 patients (22.7%) died. After adjustment, both groups of patients showed a similar risk of death at 30 days
(odds ratio: 0.70; 95% conﬁdence interval [CI]: 0.35 to 1.40; p ¼ 0.31) and up to 1 year (hazard ratio [HR]: 1.11;
95% CI: 0.74 to 1.65; p ¼ 0.62). For overall mortality, however, patients undergoing off-pump CABG were at a
signiﬁcantly higher risk of death (HR: 1.43; 95% CI: 1.19 to 1.71; p < 0.0001) compared with those undergoing on-
pump CABG. In subgroup analyses, on-pump CABG conferred survival beneﬁts in most demographic, clinical, and
anatomic subgroups compared with off-pump CABG.Conclusions In patients undergoing elective isolated CABG, on-pump strategy conferred a long-term survival advantage
compared with off-pump strategy. (J Am Coll Cardiol 2014;63:2280–8) ª 2014 by the American College of
Cardiology FoundationAfter the revival of the off-pump technique for coronary
artery bypass grafting (CABG) in the early 1990s, a number
of observational studies had shown the potential beneﬁts of
off-pump CABG over on-pump surgery. These beneﬁts
included superior neurocognitive outcomes, preservation of
renal function, and reduction in surgical bleeding and
transfusion-related complications (1–5). The enthusiasm for
off-pump technique consequently followed, especially in
eastern Asian countries: more than 60% of CABG is beingand Cardiovascular Surgery, Asan Medical
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in Japan (6,7).
Recently, large-scale, prospective randomized trials have
been conducted that showed trends toward reduced risks
of early surgical complications with off-pump CABG,
but these early beneﬁts failed to prove to be signiﬁcant
in longer-term follow-up (8–10). Moreover, off-pump
CABG had shown worse outcomes in terms of graft
patency and the requirement for coronary reintervention
compared with conventional on-pump CABG up to 1 year
after surgery (10,11). To date, results of randomized trials
are limited to within 1 year of surgery; therefore, the long-
term comparative data regarding clinical outcomes between
the 2 strategies are currently unavailable. Considering that
the beneﬁts of CABG most likely appear throughout a
long-term period, the 2 operative strategies for CABG
need to be compared using long-term follow-up data in a
reasonably sized cohort to allow adequate statistical power.
Abbreviations
and Acronyms
CABG = coronary artery
bypass grafting
CI = conﬁdence interval
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2281In this study, we sought to compare long-term survival after
off- and on-pump CABG under adequate statistical risk
adjustments through a large institutional database linked
with the National Population Registry of the Korea National
Statistical Ofﬁce.CPB = cardiopulmonary
bypass
HR = hazard ratio
IPTW = inverse-probability-
of-treatment weighting
ITA = internal thoracic artery
LV = left ventricularMethods
Patients. All patients undergoing cardiac surgery are pro-
spectively registered in our institution’s database, which re-
cords baseline patient characteristics, detailed information
on surgery, and perioperative outcomes (12). A total of
6,658 patients who underwent CABG between April 1989
and April 2012 were identiﬁed, and of them, we excluded
patients who underwent concomitant valvular or aortic
surgery (n ¼ 1,123) and those who had emergent or urgent
surgeries (n ¼ 332), thus including patients who underwent
isolated elective CABG only. Finally, 5,203 patients who
met the enrollment criteria formed the study population; of
these, 2,333 patients (44.8%) underwent off-pump CABG
whereas 2,570 (55.2%) underwent on-pump CABG. Pa-
tients who were initially intended to undergo off-pump
CABG but were converted to on-pump CABG intra-
operatively (n ¼ 46, 0.9% of all patients, 2% of off-pump
patients) were regarded as having underwent off-pump
CABG for the purposes of the intension-to-treat analyses.
The decision to perform off- or on-pump CABG was
inﬂuenced by several demographic (diabetes, renal function)
and clinical (coronary lesion category, cardiac functions) risk
proﬁles and years of surgery, but was ﬁnally at the discretion
of the attending surgeon; the authors of this study had
different attitudes regarding the use of cardiopulmonary
bypass (CPB) during CABG.
This study was approved by our institutional Ethics
Committee/Review Board, and the board waived the re-
quirement for informed patient consent due to the retro-
spective nature of the study.
Surgical procedures and medication. Most patients
(96.6%) were operated on through a median sternotomy,
whereas some of the patients receiving single- or double-
vessel off-pump CABG (n ¼ 177, 3.4%) were operated on
through mini-thoracotomy approaches. Internal thoracic ar-
teries (ITAs) were dissected in either a pedicled or skele-
tonized fashion according to the surgeon preferences. All
saphenous grafts were harvested by the open technique. The
pedicled radial artery was harvested with the use of a har-
monic scalpel or electrocautery in an open fashion. To prevent
arterial graft spasm after harvesting, a vasodilatory cocktail
was applied topically and injected intraluminally. In cases of
on-pump CABG, intermittent, antegrade blood cardioplegic
infusion (22C to 32C) was the principal strategy for
myocardial protection during aortic cross clamping. The left
ITA was used to bypass the left anterior descending artery
whenever possible. Choices of conduits and their conﬁgura-
tions for other coronary territories were determined on the
basis of conduit availability, number of distal targets, thetarget territory (right coronary vs.
left circumﬂex territories), and the
surgeon’s preference.
Statin medications and aspirin
were routinely prescribed to all of
the patients starting from post-
operative day 1 or 2 and were
continued indeﬁnitely, if not
contraindicated, through the 6-
month interval outpatient clinic
visits. The dose of statin medi-
cation was adjusted for a target
low-density lipoprotein level of
<100 mg/dl.
Study endpoints. The primary endpoint was deﬁned as all-
cause mortality, because it is the most robust and unbiased
index, requiring no adjudication to avoid inaccurate or
biased documentation and clinical assessments (13). For
validation of complete follow-up data regarding mortality,
information about vital status was obtained through
November 30, 2012, from the National Population Registry
of the Korea National Statistical Ofﬁce through the use of a
unique personal identiﬁcation number.
Statistical analysis. Categorical variables, presented as
frequencies and percentages, were compared using the chi-
square or Fisher exact test. Continuous variables, expressed
as mean  SD or median with range, were compared using
the Student unpaired t test or the Mann-Whitney U test,
as appropriate. Survival curves were constructed using
Kaplan-Meier estimates and compared with the log-rank
test.
To reduce the effect of treatment selection bias and
potential confounding, we adjusted for differences in base-
line characteristics by weighted Cox proportional-hazards
regression models with inverse-probability-of-treatment
weighting (IPTW) (14,15). With that technique, weights
for patients receiving off-pump CABG were the inverse of
the propensity score, and weights for patients receiving
on-pump CABG were the inverse of 1  propensity score.
The propensity score is the probability given baseline vari-
ables that any patient in either group would be selected for
receiving off-pump CABG. The propensity scores were
estimated without regard to outcomes by multiple logistic
regression analysis. A full nonparsimonious model was
developed that included variables shown in Table 1. Model
discrimination was assessed with C-statistics (C ¼ 0.869),
and model calibration was assessed with Hosmer-Lemeshow
statistics (p ¼ 0.497). The results of IPTW were veriﬁed by
those of propensity score matching. The propensity score–
matched pairs were created by matching between off- and
on-pump CABG subjects on the logit of the propensity
score using calipers of width equal to 0.2 of the SD of the
logit of the propensity score (16). After propensity score
matching, we examined the similarity of off- and on-pump
CABG subjects in the propensity score–matched sample
by calculating SDs for each of the baseline variables listed in












(n ¼ 1,070) SD of Mean
Age, yrs 63.1  9.3 62.8  9.0 0.25 3.2% 0.37 63.1  8.9 63.1  9.0 1.0%
Female 576 (24.7) 764 (26.6) 0.11 4.4% 0.41 256 (24.0) 274 (25.6) 3.9%
Diabetes mellitus 547 (23.4) 498 (17.4) <0.001 15.2% 0.51 257 (24.0) 250 (23.4) 1.5%
Hypertension 646 (27.7) 492 (17.1) <0.001 25.5% 0.58 262 (24.5) 253 (23.6) 2.0%
Atrial ﬁbrillation 19 (0.8) 39 (1.4) 0.063 5.3% 0.87 14 (1.3) 9 (0.8) 4.5%
Coronary lesion category <0.001 0.008
Single-vessel disease 148 (6.3) 24 (0.8) 29.9% 19 (1.8) 21 (2) 1.4%
Double-vessel disease 428 (18.3) 598 (20.8) 6.3% 209 (19.5) 230 (21.5) 4.9%
Triple-vessel disease 1,757 (75.3) 2,248 (78.3) 7.2% 842 (78.7) 819 (76.5) 5.2%
Left main involvement 559 (24.0) 648 (22.6) 0.24 3.3% 0.71 250 (23.4) 259 (24.2) 2.0%
Echocardiographic parameters
LV ejection fraction, % 57.1  10.1 56.4  11.0 0.030 6.0% 0.59 56.0  11.6 56.7  10.3 6.1%
LV systolic dimension, mm 33.1  7.6 34.2  7.8 <0.001 13.1% 0.88 33.9  8.1 33.5  7.8 5.3%
Systolic PAP, mm Hg 27.3  6.0 27.1  5.7 0.17 3.8% 0.55 27.5  6.0 27.3  6.0 3.5%
MR  moderate 31 (1.3) 47 (1.6) 0.36 2.6% 0.50 15 (1.4) 25 (2.3) 6.9%
TR  moderate 5 (0.2) 10 (0.4) 0.37 2.5% >0.99 3 (0.3) 3 (0.3) 0.0%
eGFR, ml/min/1.73 m2 74.2  26.2 72.1  21.2 0.002 8.7% 0.92 73.0  22.0 73.0  26.7 0.1%
Operator <0.001 <0.001
A 963 (41.3) 299 (10.4) 75.3% 322 (30.1) 299 (27.9) 4.7%
B 579 (24.8) 24 (0.8) 76.8% 20 (1.9) 24 (2.2) 2.6%
C 191 (8.2) 1171 (40.8) 82.0% 187 (17.5) 173 (16.2) 3.5%
D 461 (19.8) 712 (24.8) 12.2% 431 (40.3) 458 (42.8) 5.1%
E 107 (4.6) 659 (23.0) 55.3% 105 (9.8) 111 (10.4) 1.9%
F 32 (1.4) 5 (0.2) 13.7% 5 (0.5) 5 (0.5) 0.0%
Values are mean  SD or n (%), unless otherwise speciﬁed.
eGFR ¼ estimated glomerular ﬁltration rate; IPTW ¼ inverse-probability-treatment-weighting; LV ¼ left ventricle; MR ¼ mitral regurgitation; PAP ¼ pulmonary artery pressure; TR ¼ tricuspid regurgitation.
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were <0.10 (10%).
The operative year was found to be a strong discriminator
in the decision of CPB strategies for CABG. For further
adjustment for the operative years, patients were divided into
quintiles according to the operative years, then the treatment
effect was estimated separately within each quintile using the
propensity score matching, and ﬁnally, quintile estimates
were combined to measure an overall estimate of the treat-
ment effect (17).
For subgroup analyses, a new propensity score for off-
pump CABG versus on-pump CABG was calculated in
each subgroup, and the individual propensity score was
incorporated into the Cox regression model as a covariate and
type of CABG to calculate the propensity-adjusted hazard
ratio (HR). All statistical analyses were performed with SAS
version 9.1 (SAS Institute, Cary, North Carolina). A 2-tailed
p value <0.05 was considered to be statistically signiﬁcant.
Results
Baseline characteristics and coronary grafting proﬁles.
The baseline demographic and clinical characteristics of the
patients are shown in Table 1 (left columns). Patients who
underwent off-pump CABG were more likely to have dia-
betes, hypertension, and single-vessel coronary disease than
those who underwent on-pump CABG. Left ventricular(LV) ejection fraction was higher, LV systolic dimension
was smaller, and renal function was superior in the off-
pump than in the on-pump CABG group. In the selec-
tion of CABG strategy, there were signiﬁcant inﬂuences of
the surgeon factor and surgical years (Fig. 1). After
adjustment of the baseline proﬁles with the use of IPTW,
there were no signiﬁcant inter-group differences in baseline
covariates except for coronary lesion category and operator,
whereas propensity score matching yielded a cohort that was
well balanced for all baseline covariates (Table 1, right
columns).
Regarding the coronary bypass grafting proﬁles, patients
undergoing off-pump CABG had fewer distal anastomoses,
but more frequently had the use of arterial conduits,
including higher rates of total arterial grafting and bilateral
ITA grafting, compared with those undergoing on-pump
CABG (Table 2).
Unadjusted mortality. The 30-day mortality rates were
0.9% (n ¼ 21) in the off-pump CABG group and 1.4%
(n ¼ 41) in the on-pump CABG group (p ¼ 0.095).
Follow-up data regarding mortality was complete in 99.3%
of patients (n ¼ 5,167), with a median follow-up duration of
6.4 years (interquartile range: 3.7 to 10.5 years; maximum
23.1 years). During this period, 1,181 patients (22.7%) died.
The Kaplan-Meier curve did not show a signiﬁcant differ-
ence in mortality up to 1 year (Fig. 2A); however, in the
Figure 1
Trends in Cardiopulmonary Bypass Strategies
for CABG
Trends in cardiopulmonary bypass strategies for coronary artery bypass grafting
(CABG) during the study period at the Asan Medical Center, Seoul, Korea.
Figure 2 Unadjusted Kaplan-Meier Curves for Death
Up to 1 year, there is no signiﬁcant difference between the on- and off-pump
groups (A); however, the difference becomes signiﬁcant later in favor of on-pump
surgery compared with off-pump surgery (B).
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favor of on-pump CABG over off-pump CABG (Fig. 2B).
Adjusted mortality. After adjustment with IPTW, there
was no signiﬁcant difference in the death rate at 30 days
(odds ratio: 0.70; 95% CI: 0.35 to 1.40; p ¼ 0.31) and up to
1 year (HR: 1.11; 95% CI: 0.74 to 1.65; p ¼ 0.62). For
overall mortality, off-pump CABG showed a higher risk of
death (HR: 1.43; 95% CI: 1.19 to 1.71; p < 0.0001)
compared with on-pump CABG. When the adjustment
(IPTW) was further augmented by multivariable analyses
(IPTW þ multivariable analyses) including 2 baseline var-
iables that were signiﬁcantly different after IPTW (coronary
lesion category and operator), off-pump CABG still showed
a higher risk of death than on-pump CABG. Results from
the propensity score–matched cohort were also similar for




(n ¼ 2,870) p Value
Number of distal
anastomoses
3.0  1.1 3.7  1.2 <0.001
1 245 (10.5) 47 (1.6)
2 508 (21.8) 398 (13.9)
3 820 (35.1) 896 (31.2)
4 760 (32.6) 1,529 (53.3)
Use of bilateral ITA 292 (12.5) 131 (4.6) <0.001
No use of ITA 62 (2.7) 212 (7.4) <0.001
Total arterial grafting in
multivessel disease
869/2,113 (41.1) 630/2,669 (23.6) <0.001
Use of radial artery 1,341 (57.5) 1,444 (50.3) <0.001
Use of gastroepiploic
artery
120 (5.1) 238 (8.3) <0.001
Use of saphenous vein 1,283 (55.0) 2,212 (77.1) <0.001
Values are mean  SD, n (%), or n/N (%).
ITA ¼ internal thoracic artery.and overall mortality (p < 0.0001) as those of the IPTW
(Table 3). Adjusted outcomes by various statistical methods
are detailed in Table 3, showing consistent results in favor of
on-pump CABG in long-term survival regardless of the
statistical methods used.
Because the operative year had a strong determinant in the
selection of operative strategy (Fig. 1), further adjustments
for the operative years were performed through stratiﬁcation
methods. Consequently, the higher risk of death in patients
undergoing off-pump CABGwas still observed in the overall
cohort and in propensity score–matched patients compared
with those undergoing on-pump CABG (Table 4).
Subgroup analyses. Figure 3 reveals adjusted HRs for all-
cause mortality in off-pump CABG compared with on-
pump CABG in various demographic and clinical risk
subgroups. The poorer survival for off-pump CABG was
observed in most subgroups; the only exception was patients
with single-vessel coronary disease.
Table 3
Adjusted HRs for Death Following Off-Pump CABG
Compared With On-Pump CABG
Outcomes OR or HR 95% CI p Value
30-day mortality
Crude 0.63 0.37–1.06 0.084
IPTW 0.70 0.35–1.40 0.31
IPTW þ multivariable* 0.67 0.41–1.09 0.11
Propensity score matching 0.82 0.41–1.67 0.59
1-yr mortality
Crude 1.05 0.79–1.39 0.75
IPTW 1.11 0.74–1.65 0.62
IPTW þ multivariable* 1.05 0.66–1.66 0.83
Propensity score matching 1.33 0.88–2.01 0.18
Overall death
Crude 1.22 1.07–1.38 0.0035
IPTW 1.43 1.19–1.71 <0.0001
IPTW þ multivariable* 1.47 1.30–1.67 <0.0001
Propensity score matching 1.48 1.23–1.79 <0.0001
Odds ratios (ORs) are listed for 30-day mortality, and hazard ratios (HRs) are listed for 1-year
mortality and overall death. *Weighted Cox proportional hazards regression models incorporated
coronary lesion category and operator.
CABG ¼ coronary artery bypass grafting; CI ¼ conﬁdence interval; IPTW ¼ inverse-probability-
treatment-weighting.
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grafting proﬁles and operator, the higher risk of death in the
off-pump CABG group was consistently observed regardless
of whether total arterial grafting was performed, bilateral
ITA was used, or no ITA was used, although there was a
signiﬁcant interaction in the inﬂuence of CABG strategy on
mortality according to the operators (Table 5).Discussion
The results of the present study showed that, despite similar
early mortality between off- and on-pump CABG, on-
pump CABG conferred a superior survival beneﬁt over
off-pump CABG in the long term. These results are derived
from a large set of data to compare the outcomes of the
2 strategies, and rigorous statistical adjustments were con-
ducted considering the “surgeon factor” and the “year of
operation” as well as other important covariates in the sta-
tistical models. It is a noteworthy fact that these results wereTable 4
HRs for Death Following Off-Pump CABG Compared With On
Operative Years in Quintiles
Death
All Cohort
On-Pump Off-Pump HR 95% CI
q1 (1989w1999) 471/1,018 12/22 1.57 0.88–2.78
q2 (1999w2003) 162/678 104/364 1.26 0.98–1.61
q3 (2003w2006) 113/606 100/435 1.42 1.08–1.86
q4 (2006w2008) 49/385 99/655 1.22 0.87–1.72
q5 (2008w2012) 16/183 55/857 0.88 0.50–1.53
Summary* 811/2,870 370/2,333 1.29 1.11–1.50
Values are n/N unless otherwise indicated. *Likelihood ratio test for homogeneity; p ¼ 0.57 for overall
q ¼ quintile; other abbreviations as in Table 3.obtained from one of the most enthusiastic centers to
perform off-pump CABG in the world.
There has been a resurgence in off-pump CABG in the
1990s on the basis of the various purported advantages
attributed to avoiding extracorporeal circulation during
CABG. The most notable merits, as suggested by several
observational studies, included avoiding embolic stroke
induced by invasive aortic manipulation and reducing
coagulopathy and renal dysfunction (4,5). The advent of
all-arterial left ITA-composite bypass grafting and the
implications for avoiding aortic manipulation has spurred
the enthusiasm for off-pump CABG as a means of reaping
the full beneﬁts of both strategies. In North America,
approximately 10% to 20% of all CABGs have been
steadily performed by off-pump CABG (18). In Japan,
however, over 60% of the cases were reported to be per-
formed by off-pump CABG in the 2000s (6). Similarly,
there has been a steep acceptance of off-pump CABG in
the last decade in Korea beginning in 2000, when 24.5% of
the cases used the off-pump technique, to 2008, when
66.2% of cases were off-pump CABG (7). Keeping pace
with these trends, off-pump CABG has also been enthu-
siastically embraced in our institution, with an eventual
reversal in the numbers of on-pump CABG by off-pump
CABG. Of note, among patients who underwent CABG
in our center from January 2011 through April 2012,
94.2% of patients (293 of 311) underwent off-pump
CABG.
With increasing volumes of off-pump CABG, numerous
studies have attempted to assess if off-pump CABG was
actually superior to on-pump surgery. Takagi et al. (19)
showed a survival beneﬁt of on- over off-pump CABG
through a meta-analysis of 18 randomized controlled trials
assessing the mean 1-year follow-up results, in which there
was a 35% greater late mortality associated with off-pump
CABG over on-pump CABG (odds ratio: 1.35; 95% CI:
1.07 to 1.70; p ¼ 0.01). The ROOBY (Veterans Affairs
Randomized On/Off Bypass) trial, one of the largest pub-
lished randomized controlled studies comparing the
outcome of on- and off-pump CABG, also showed greater
adverse composite outcomes of all-cause mortality, revas-
cularization, and nonfatal myocardial infarction with-Pump CABG: Stratiﬁed Analysis Based on
Propensity Score Matching
p Value On-Pump Off-Pump HR 95% CI p Value
0.12 9/21 11/21 1.28 0.62–2.63 0.51
0.069 30/138 43/138 1.67 1.07–2.61 0.024
0.011 27/123 31/123 1.30 0.76–2.225 0.34
0.25 21/173 33/173 1.77 1.01–3.11 0.046
0.64 14/144 14/144 1.10 0.50–2.39 0.81
0.0012 101/599 132/599 1.48 1.14–1.90 0.0028
cohort, p ¼ 0.80 for propensity score-matched cohort.
Figure 3 Hazard Ratios for Mortality in Off-Pump Surgery Compared With On-Pump Surgery
Adjusted hazard ratios for mortality in off-pump surgery compared with on-pump surgery according to various risk subgroups. DM ¼ diabetes mellitus; GFR ¼ glomerular ﬁltration
rate; LM ¼ left main; LV ¼ left ventricular; LVEF ¼ left ventricular ejection fraction; VD ¼ vessel disease.
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2285off-pump CABG (10). However, neither the ROOBY trial
nor the DOORS (Danish On-Pump versus Off-Pump
Randomization Study), consisting of 900 patients, was
sufﬁciently powered to support the between-group clinical
differences with respect to death (10,20). Furthermore,
because the largest-scale studies have been limited to 1-yearTable 5 Adjusted HRs for Death Following Off-Pump CABG Compared
Off-Pump On-Pump
Multivessel grafting
Use of venous grafts 172/1,072 582/2,039
Total arterial grafting 153/869 112/630












Values are number of deaths divided by number of patients (n/N) unless otherwise indicated.
BITA ¼ bilateral internal thoracic artery; ITA ¼ internal thoracic artery; other abbreviations as in Tableoutcome analysis, the long-term differences in adverse out-
comes between the 2 strategies have not been evaluated
appropriately (8–10).
Criticisms for the ROOBY trial in particular included a
possible bias toward including relatively low-risk patients, an
excessively high on-pump conversion rate (12.4%), and aWith On-Pump CABG: Stratiﬁed by Operators and Grafting Proﬁles
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2286relatively small sample size (n ¼ 2,203). To address these
issues, a large international trial that enrolled 4,752 patients,
CORONARY (CABG Off or On Pump Revascularization
Study), was conducted (8,9). A strict criterion was applied to
include only experienced surgeons (21). The adequacy of
surgeon experience and expertise was determined according
to the criteria outlined in the expertise-based, randomized
controlled trial described previously. The 1-year results
showed no signiﬁcant differences between the 2 groups
with regard to death, nonfatal stroke, nonfatal myocardial
infarction, or renal failure. Therefore, unlike the ROOBY
trial, the outcomes clearly did not support on-pump CABG
as being superior to off-pump CABG and perpetuated the
controversy regarding the question of which of the 2 stra-
tegies is superior.
In the present study, 5,203 elective coronary bypass surgery
patients were divided into 2 groups on the basis of the car-
diopulmonary support strategy. The patient population size
was adequate to power the statistical analysis. Propensity
scoring and IPTW were used to match the important differ-
ences in the baseline risk proﬁles that may otherwise have
affected the outcomes. Due to the participation by multiple
surgeons, rigorous statistical adjustments were made to
eliminate the effects of the individual surgeon factor on
the outcome. The participation of highly experienced and
skilled surgeons is a notable strength of this study. The results
showed no signiﬁcant differences in the 30-day and 1-year
mortality outcomes, although there was a slight tendency to
favor the off-pump CABG group in this early period. The
long-term survival rate beyond the ﬁrst year, as illustrated
in the Kaplan-Meier survival curves, however (Fig. 2B),
was more favorable to patients receiving on-pump CABG,
and suggested a sustained negative independent impact by
off-pump CABG on the long-term outcome. This study is
1 of few large-scale clinical studies comparing the long-term
outcomes of off- versus on-pump CABG, and the results
were consistent with the recent Veterans Affairs study re-
ported by Bakaeen et al. (22), which found no signiﬁcant
differences in the earlier survival outcome up to 3 years but
a signiﬁcant increase in the risk-adjusted mortality in the
off-pump CABG group at 5 and 10 years. In light of the
intuitive expectations that were generally held for off-
pump CABG, the inferior outcomes by off-pump CABG
in our and other studies were all the more remarkable
and surprising.
Signiﬁcantly more target vessel bypasses were performed
in the on-pump group: 3.7  1.2 versus 3.0  1.1 in the
off-pump CABG group (p < 0.001). A greater number of
bypasses and subsequently a higher complete revasculariza-
tion rate were also reported in the on-pump group in the
ROOBY trial. Previous studies have reported that the
completeness of revascularization was important in en-
hancing patient survival (23,24). We also attributed the
superior long-term survival rate in the on-pump CABG
group to the higher rate of complete revascularization.
Although the signiﬁcantly higher prevalence of single-vesseldisease patients in the off-pump CABG group is arguably a
factor that may lower the mean number of target vessel
bypasses, the number was too small and, furthermore, it
should have rather acted to enhance the survival outcomes in
the off-pump CABG group.
Complete data regarding graft patency on the basis of
angiographic or computed tomography imaging studies have
not been available in this study, but major clinical trials
including the ROOBY trial have shown superior long-term
graft patency and quality of graft patency after on-pump
CABG. Superior graft patency status and a higher Fitz-
Gibbon A patency were observed throughout the spectrum of
graft conduits used in the on-pump CABG patients. These
ﬁndings were consistent with other similar trials showing
superior graft patency with on-pump CABG (25–27). This
may explain the higher repeat revascularization rate in the
off-pump CABG group in the ROOBY and other large
nonrandomized trials (11,28,29).
The adjusted HRs for all of the risk groups for mortality
in the present study overwhelmingly favored on- over
off-pump CABG (Fig. 3). These results clearly showed that
any risks associated with CPB were limited to the early
post-operative period. The signiﬁcantly decreased long-term
survival associated with off-pump CABG in the Veterans
Affairs study was consistent with other large single-center
observational studies (22,30,31). Based on the results of
our trial and other large-scale clinical trials, the beneﬁts of
avoiding extracorporeal circulation with off-pump CABG
do not seem to be long-lasting, and they are unable to offset
the greater long-term risks of mortality associated with
off-pump CABG. Therefore, it seems reasonable to suggest
that the enthusiasm for off-pump CABG as the CABG
strategy of choice should be reappraised.
Emergency cross-over from off- to on-pump CABG is
known to increase the risks of early mortality and morbidity
(32). If the 2 strategies were compared “as treated,” there
would have been critical errors in categorizing “on-pump
conversion” patients to the “on-pump” group. The study re-
sults would have been misleading, as the early surgical results
of the nonconverted off-pump CABG patients would have
been more favorable than the subgroup of patients that had
undergone pump conversion. This is why the comparison
of the 2 CABG strategies in the present study was conducted
as an “intention-to-treat” rather than “as treated” analysis.
Our institutional database contained the critical information
needed to determine the initial and actual CABG CPB
strategy that was employed; 46 patients had converted to
on-pump CABG intraoperatively from a failed initial off-
pump attempt. These patients were correctly assigned to
the off-pump group for the purposes of the present study.
Consequently, the early mortality rate, which was 6.5%
(3 of 46) in the patients who experienced such conversion,
was signiﬁcantly higher than in those who were able to
complete the surgery as initially planned (mortality rate:
0.7% [17 of 2,286]; p ¼ 0.006). Furthermore, long-term
survival was also compromised in these on-pump
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2287conversion patients, as evidenced by the 5-year survival rate of
70.7  0.8%, which was signiﬁcantly lower than the 86.8 
0.8% in those patients that had not undergone such conver-
sion (p ¼ 0.001).
Study limitations. This study is subject to the limitations
inherent to a retrospective analysis of observational data. The
decision to perform off- versus on-pump CABG was
strongly affected by the surgeons’ preferences and the years
of the operation, as well as several other important baseline
demographic and clinical proﬁles. Although we tried to
rigorously adjust selection bias using multiple sophisticated
statistical methods, such as propensity score-based analyses,
unmeasured confounders, procedure bias, or detection bias
may have affected our results.
All-cause mortality has been used as the primary
outcome of interest in a number of studies on cardiovas-
cular disease as it is regarded as the most robust and un-
biased index. The present study also used this index to
avoid potentially inaccurate or biased documentation and
clinical assessments. The availability of survival data, which
we obtained from the Korea National Statistical Ofﬁce,
was nearly 100% complete. However, obtaining detailed,
complete clinical follow-up data regarding other outcomes,
such as cardiac death, stroke, repeat revascularization, and
myocardial infarction, in our large set of data was, for all
practical purposes nearly impossible. Therefore, one of the
major limitations of this study is that we did not evaluate
such outcomes.Conclusions
Off-pump CABG was associated with increased long-term
mortality compared with on-pump CABG. This ﬁnding
was consistent when the analyses were further stratiﬁed by
grafting results, and the higher risk of death with off-pump
CABG appeared in most risk subgroups. Further studies are
needed to improve our understanding of the mechanism by
which on-pump CABG confers enhanced long-term sur-
vival, as well as to identify the subsets of patients in which
the beneﬁts of this technique can be maximized.
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